Comparative Efficacy and Acceptability of Antidepressants in Parkinson's Disease: A Network Meta-Analysis

Open Access

Peer-reviewed

Research Article

Jinling Liu ,

Contributed equally to this work with: Jinling Liu, Jiangchuan Dong

Affiliation Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
⨯
Jiangchuan Dong ,

Contributed equally to this work with: Jinling Liu, Jiangchuan Dong

Affiliation Department of Traditional Chinese Medicine, Chongqing Medical University, Chongqing, China
⨯
Lei Wang,

Affiliation Department of Neurology, Weifang People's Hospital, Weifang, Shandong, China
⨯
Ying Su ,

* E-mail: suying0110@126.com

Affiliation Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
⨯
Peng Yan,

Affiliation Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
⨯
Shenggang Sun

Affiliation Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
⨯

Parkinson disease
Is the Subject Area "Parkinson disease" applicable to this article?

Thanks for your feedback.
Antidepressants
Is the Subject Area "Antidepressants" applicable to this article?

Thanks for your feedback.
Depression
Is the Subject Area "Depression" applicable to this article?

Thanks for your feedback.
Metaanalysis
Is the Subject Area "Metaanalysis" applicable to this article?

Thanks for your feedback.
Antidepressant drug therapy
Is the Subject Area "Antidepressant drug therapy" applicable to this article?

Thanks for your feedback.
Randomized controlled trials
Is the Subject Area "Randomized controlled trials" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Dopamine
Is the Subject Area "Dopamine" applicable to this article?

Thanks for your feedback.